CRGO · Freightos Ltd · Insider Trading

The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 40,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on April 1, 2025. 33.33% of such RSUs vested on April 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2028).

The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") granted to the Reporting Person by the Issuer.

The 20,000 ordinary shares reported in this row will be issuable upon vesting and settlement of RSUs, in their entirety, on December 31, 2029.

The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") granted to the Reporting Person by the Issuer.

The 40,000 ordinary shares reported in this row will be issuable upon vesting and settlement of RSUs in accordance with the following schedule: 33.33% of the RSUs will vest upon the one-year anniversary of the vesting commencement date (September 1, 2027), and the remaining RSUs will vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such 40,000 RSUs will be fully vested by the three-year anniversary of the vesting commencement date (September 1, 2029).

The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") granted to the Reporting Person by the Issuer.

The 20,000 ordinary shares reported in this row will be issuable upon vesting and settlement of RSUs, in their entirety, on December 31, 2028.

The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 5,850 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. Such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) are now fully vested and have been settled for underlying ordinary shares. In addition to the 199 shares sold as reported in this row and the 193 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 1,856 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 3,602 ordinary shares are currently held by the Reporting Person from the 5,850 RSUs originally granted.

The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 30,820 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. Such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) are now fully vested and have been settled for underlying ordinary shares. In addition to the 1,175 shares sold as reported in this row, the 2,904 shares from this grant sold on May 28, 2026 as reported in the Form 4 filed on June 1, 2026, and the 1,170 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 24,177 shares were sold (in certain cases, to cover tax liability) previously (before the Reporting Person was subject to Section 16), such that only 1,394 ordinary shares are currently held by the Reporting Person from the 30,820 RSUs originally granted.

The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 35,480 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following ten quarters (6.66% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by December 31, 2027.

In addition to the 1,353 shares sold as reported in this row, and the 1,347 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 16,006 shares were sold (in certain cases, to cover tax liability) previously (before the Reporting Person was subject to Section 16), such that only 16,774 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 35,480 RSUs originally granted.

The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 7,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on October 15, 2025. Such RSUs have vested in full as of July 15, 2026 (reduced by any RSUs for which underlying shares have been sold to cover tax liability). In addition to the 760 shares sold as reported in this row and the 756 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 754 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 4,730 ordinary shares are currently held by the Reporting Person from the 7,000 RSUs originally granted.

The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 19,830 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be fully vested by July 15, 2027.

In addition to the 672 shares sold as reported in this row and the 653 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 3,862 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 14,643 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 19,830 RSUs originally granted.

The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 21,500 RSUs originally granted by the Issuer to the Reporting Person that began vesting on October 15, 2025. Such RSUs vest equally on a quarterly basis over seven calendar quarters (approximately 14.286% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by July 15, 2027. In addition to the 1,000 shares sold as reported in this row and the 995 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 992 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 18,513 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 21,500 RSUs originally granted.

The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 28,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2025. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date (July 15, 2026), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be fully vested by July 15, 2028.

The transaction reported in this row consists of the sale of ordinary shares on behalf of the Reporting Person to satisfy applicable withholding tax obligations arising from the vesting of restricted share units ("RSUs") previously granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 36,000 RSUs originally granted to the Reporting Person by the Issuer that began vesting on July 1, 2025. 33.33% of such RSUs vested on July 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (July 1, 2028).

The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 40,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on April 1, 2025. 33.33% of such RSUs vested on April 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2028).

The transaction reported in this row consists of the sale of ordinary shares on behalf of the Reporting Person to satisfy applicable withholding tax obligations arising from the grant of ordinary shares to the Reporting Person upon his achievement of performance criteria under performance share units ("PSUs") previously granted by the Issuer to the Reporting Person.

The transaction reported in this row consists of the grant of ordinary shares to the Reporting Person by the wholly-independent compensation committee of the board of directors of the Issuer upon the Reporting Person's achievement of performance criteria under performance share units (PSUs) previously granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. The 30,820 RSUs originally granted vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date, and the remainder of those RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such 30,820 RSUs (reduced by any RSUs for which underlying shares have been sold) will be vested by the three-year anniversary of the vesting commencement date (July 15, 2026).

The transaction reported in this row consists of an amendment to an existing grant of restricted shares units ("RSUs") to the Reporting Person, which amendment was approved by the Issuer's board of directors on April 28, 2026. Under the amended terms, the Reporting Person received a finite number of additional ordinary shares represented by RSUs currently, with an annual vesting schedule, instead of being entitled to receive indeterminable numbers of additional ordinary shares at later dates based on the market price of the Issuer's ordinary shares at such later dates.

Under the prior grant terms, the Reporting Person had been granted 24,390 ordinary shares represented by 24,390 RSUs that began vesting on July 28, 2025 and that were to vest (and settle for 24,390 underlying ordinary shares) on the one-year anniversary of the vesting commencement date (July 28, 2026) (in addition to indeterminable numbers of additional ordinary shares to be granted later). Under the revised grant terms, in lieu of those future grants, the Reporting Person received a finite, additional 97,562 ordinary shares currently, represented by 97,562 RSUs, such that the total grant has been set at 121,952 ordinary shares represented by 121,952 RSUs.

The subject 121,952 ordinary shares consist of shares underlying 121,952 RSUs that will vest and settle in equal annual installments, for 30,488 ordinary shares each, on the first four anniversaries of the original July 28, 2025 grant date, such that all 121,952 ordinary shares will be received by the Reporting Person by July 28, 2029.

The transaction reported in this row consists of a sale-to-cover on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. The 30,820 RSUs originally granted vest in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such 30,820 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by the three-year anniversary of the vesting commencement date (July 15, 2026).

The transaction reported in this row consists of a sale-to-cover on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. The 35,480 RSUs originally granted vest in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following ten quarters (6.66% per quarter) such that all such 35,480 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by December 31, 2027.

The transaction reported in this row consists of a sale-to-cover (to cover tax liability) on behalf of the Reporting Person of ordinary shares received upon vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 7,000 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over three calendar quarters (33.33% per quarter) such that all such 7,000 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2026.

The transaction reported in this row consists of a sale-to-cover on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on July 15, 2024 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: Of the 19,830 RSUs originally granted, 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remainder of those RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such 19,830 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by the three-year anniversary of the vesting commencement date (July 15, 2027).

The transaction reported in this row consists of a sale-to-cover (to cover tax liability) on behalf of the Reporting Person of ordinary shares received upon vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 21,500 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over seven calendar quarters (approximately 14.286% per quarter) such that all such 21,500 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2027.

The transaction reported in this row consists of a sale-to-cover on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on July 15, 2023 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: Of the 5,850 RSUs originally granted, 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remainder of those RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such 5,850 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by the three-year anniversary of the vesting commencement date (July 15, 2026).

The transaction reported in this row consists of a sale-to-cover on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.

The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: Of the 40,000 RSUs originally granted, 33.33% of the RSUs vested upon the one-year anniversary of the grant date (April 1, 2026) and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date.

The transaction reported in this row consists of a grant to the Reporting Person of 40,000 restricted share units ("RSUs") that was approved by the Issuer's board of directors.

The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).

The transaction reported in this row consists of a sale-to-cover on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.